Year: 2024
Type: review
Source: Cell Metabolism
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: European Federation of Pharmaceutical Industries and Associations, National Institute for Health and Care Research, European Commission, Innovative Medicines Initiative, National Institutes of Health, Horizon 2020 Framework Programme, NIHR Newcastle Biomedical Research Centre, National Institute on Alcohol Abuse and Alcoholism, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences
Awards: A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?, Liver Investigation: Testing Marker Utility in Steatohepatitis, G2912381425, Non-invasive screening of diabetics for advanced fibrosis due to NAFLD, Novel IL-23 inhibitor for the treatment of alcohol associated liver disease, G434337789, NIHR Senior Investigator Award, Ancillary Studies of NAFLD and NASH in HIV infected Adults, QUS Technology for Diagnosis and Grading of Hepatic Steatosis in NAFLD, UC San Diego Clinical and Translational Research Institute, San Diego Digestive Diseases Research Center, Clinical Research on Nonalcoholic Fatty Liver Disease, San Diego Cirrhosis Clinical Research Network, G969404240
OpenAlex ID: W4394714984
